Cardiovascular risk with SCORE system in patients with different degree of renal function impairment

Boriana Deliyska1, Ventzislav Shurliev, Nencho Nenchev

  • 1Medical University, Sofia, Bulgaria. delijska@yahoo.com

Medicinski Pregled
|October 22, 2008
PubMed

Insights

The Systematic Coronary Risk Evaluation (SCORE) system may underestimate cardiovascular risk in patients with chronic kidney disease. This study found higher calculated risks in predialysis patients compared to those without renal impairment.

Area of Science:

  • Cardiology
  • Nephrology
  • Public Health

Background:

  • The Systematic Coronary Risk Evaluation (SCORE) system is a European-based tool for assessing 10-year fatal cardiovascular event risk.
  • Renal impairment is a known risk factor for cardiovascular disease, but its impact on SCORE predictions requires further investigation.

Purpose of the Study:

  • To compare cardiovascular risk calculated using the SCORE system in patients with varying degrees of renal impairment.
  • To evaluate the accuracy of the SCORE system in high-risk populations, specifically those with chronic kidney disease.

Main Methods:

  • Ninety patients were stratified into four groups: no renal failure, predialysis chronic renal failure (CRF), hemodialysis non-diabetic, and hemodialysis diabetic.
  • SCORE was calculated based on age, sex, systolic blood pressure, smoking status, and cholesterol levels.
  • Statistical analysis was performed to compare SCORE values across the four groups.

Main Results:

  • No significant differences in age or blood pressure were observed between the groups.
  • Predialysis patients exhibited higher incidences of smokers and elevated cholesterol levels.
  • The highest SCORE values were recorded in the predialysis group (5.3+/-4.3), followed by the hemodialysis diabetic (4.06+/-4) and hemodialysis non-diabetic (3.7+/-1.1) groups, compared to the control group (2.5+/-1.8).

Conclusions:

  • The SCORE system's traditional risk factors appear insufficient to fully capture cardiovascular risk in patients with chronic kidney disease.
  • The SCORE system may underestimate the actual cardiovascular risk in high-risk groups, such as patients with chronic renal disease.
  • Further refinement of risk prediction models is needed for populations with renal impairment.

Related Concept Videos

Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate01:25

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate

The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...